May 14, 2018 / 10:17 AM / 12 days ago

BRIEF-Fennec Pharmaceuticals Reports Q1 Loss Per Share Of $0.09

May 14 (Reuters) - Fennec Pharmaceuticals Inc:

* FENNEC PROVIDES BUSINESS UPDATE AND ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS

* FENNEC PHARMACEUTICALS INC - CASH AND CASH EQUIVALENTS WERE $26.7 MILLION AS OF MARCH 31, 2018

* FENNEC PHARMACEUTICALS - CASH AND CASH EQUIVALENTS AS OF MARCH 31, 2018 SUFFICIENT TO FUND PLANNED COMMERCIAL LAUNCH OF PEDMARK IN H2 OF 2019

* FENNEC PHARMACEUTICALS INC - QTRLY LOSS PER SHARE $0.09 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below